Dysregulated activation of the NF-κB transcriptional activity contributes to development of inflammation-associated prostatic diseases such as benign prostate hyperplasia (BPH) and prostate cancer [18–21]. The gene discussed is NFKB1; the disease is benign prostatic hyperplasia.